KPTI earnings: a positive outcome, +21.3%

On February 12, 2026, Karyopharm Therapeutics Inc. reached its earnings. The result was a positive outcome, and the stock moved +21.3% in the window around the event. It had already run -20.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.